Form 4: IGM Biosciences Director Receives Stock as Partial Retainer Payment

Elizabeth H.Z. Thompson, a director at IGM Biosciences, acquired 694 shares of common stock as partial payment of a quarterly retainer.

Summary

• On March 31, 2025, Elizabeth H.Z. Thompson, a director of IGM Biosciences, acquired 694 shares of common stock.
• The acquisition was a result of a partial payment of a quarterly retainer in common stock, according to the Issuer's Outside Director Compensation Policy.
• The price per share was $0.
• Following the transaction, Thompson directly owns 6,502 shares of IGM Biosciences common stock.
• The transaction was reported on April 2, 2025.

Sentiment

Score: 6

Explanation: Neutral sentiment. The transaction is a routine compensation matter and doesn't necessarily indicate a strong positive or negative outlook for the company.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This transaction reflects standard compensation practices for board members.

Related Party Transactions

• The stock grant to the director is a related party transaction.

Stakeholder Impact

• The transaction has a minimal impact on stakeholders as it is a standard compensation practice.

Key Dates

Keywords

IGM Biosciences, Director, Stock Acquisition, Form 4, Elizabeth H.Z. Thompson, Retainer, Common Stock